stockrow
Monday 9 November 2026
Export ADGM’s income statement to Excel — free account
Adagio Medical Holdings, Inc.
ADGMAdagio Medical Holdings, Inc.’s revenue for fiscal 2024 (year ended December 2024) was $602,000.00, up 100.7% from fiscal 2023.
- Revenue
- −33.5%
- EPS
- −15.4%
- Free cash flow
- −12.9%
- Total debt
- +46.6%
Quarter to June 2026, against a year earlier
0.06
0.00
0.00%
Follow ADGM
Alert me
Adagio Medical Holdings, Inc. (ADGM) P/E ratio
Adagio Medical Holdings, Inc. has no meaningful P/E ratio: its trailing twelve-month earnings is negative. Over the past ten years it has ranged from 0.0× (November 2026) to 36.2× (March 2023) — the current reading is the lowest in ten years.
P/E ratio, daily
Embed this chart
Annual newest first
| Period | P/E ratio | Change |
|---|---|---|
| FY2024 | 0.0× | — |
| FY2023 | 0.0× | — |
Quarterly newest first
| Period | P/E ratio | Change |
|---|---|---|
| Dec 2024 | 0.0× | — |
| Sep 2024 | 0.0× | — |
| Jun 2024 | 0.0× | — |
| Mar 2024 | 0.0× | — |
| 2 more quarters | Free account |
Against its own ten years
Low 0.0×
High 36.2×
Ten-year median
0.0×
Current reading's percentile
85
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| NUVOQ Holdco Nuvo Group D.G Ltd. compare | n/m |
| ICCM IceCure Medical Ltd. compare | n/m |
| DHAI DIH Holding US, Inc. compare | n/m |
| BJDX Bluejay Diagnostics, Inc. compare | n/m |
| NXL Nexalin Technology, Inc. compare | n/m |
| CODX Co-Diagnostics, Inc. compare | n/m |
| ADGM Adagio Medical Holdings, Inc. | n/m |
| IVF INVO Fertility, Inc compare | n/m |
| GCTK GlucoTrack, Inc. compare | n/m |
| Medical Devices industry median | 24.9× |
| Healthcare sector median | 24.5× |
| Market median | 17.8× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)